Epidemiological, procedure and market data are presented for four market geographies, including the United States, Major Europe (the five largest Western European States), Major Asia-Pacific (encompassing China, India and Japan), and Rest of the World nations. The report projections are based on detailed, clinical and econometric models for the years 2013 through 2019 that are intended to act as a working tool for clients of the report. They provide dynamic models of the covered technologies' utilization patterns and revenue growth within the context of neurointerventional radiology practices in the targeted regions, historic analogies of adoption of similar transcatheter tools and techniques, priorities in local healthcare policies, and the availability of funding, among other factors.
EXECUTIVE SUMMARY 1. Epidemiology and Patients 1.1 Hemorrhagic Stroke 1.1.1 Intracerebral Hemorrhage (ICH) 18.104.22.168 Causes, Risk Factors and Symptoms 22.214.171.124 Incidence and Patients by Major Geography 126.96.36.199 Treatment of Acute ICH 1.1.2 Subarachnoid Hemorrhage (SAH) 188.8.131.52 Causes, Risk Factors and Symptoms 184.108.40.206 Incidence and Patients by Major Geography 220.127.116.11 Treatment of Acute SAH 1.1.3 Cerebral Aneurysms, Arteriovenous Malformations and Hemorrhagic Stroke 1.2 Ischemic Stroke 1.2.1 Thrombotic Stroke - Causes & Mechanisms 1.2.2 Embolic Stroke - Causes & Mechanisms 1.2.3 Hypoperfusion Stroke - Causes & Mechanisms 1.2.4 Symptoms and Risk Factors for Ischemic Stroke 1.2.5 Incidence and Patients by Major Geography 1.2.6 Treatment of Acute Ischemic Stroke 2. Interventional Tools and Techniques for Acute Stroke Management 2.1 Prophylaxis of Hemorrhagic Stroke 2.1.1 Treatment of Cerebral Aneurysms and AVMs 18.104.22.168 Embolization Technologies 22.214.171.124.1 Microcoil Systems 126.96.36.199.2 Liquid Embolic Systems 188.8.131.52.3 Embolization Enabling Stenting Systems 184.108.40.206.4 Cerebral Embolization Procedure Volumes 2.2 Prophylaxis and Treatment of Acute Ischemic Stroke 2.2.1 Carotid Artery Stenting (CAS) 220.127.116.11 Stenting versus Endarterectomy 18.104.22.168 CAS Systems 22.214.171.124 Embolic Protection Devices 126.96.36.199 CAS Procedure Volumes 2.2.2 Left Atrial Appendage (LAA) Closure 188.8.131.52 LAA Closure Technologies 184.108.40.206 LAA Closure Procedure Volumes 2.2.3 Cerebral Thrombectomy 220.127.116.11 Cerebral Thrombectomy Devices 18.104.22.168 Cerebral Thrombectomy Procedure Volumes 2.2.4 Intracranial Stenting 22.214.171.124 Intracranial Stenting Technologies 126.96.36.199 Intracranial Stenting Procedure Volumes 3. Global Markets for Interventional Acute Stroke Therapies 3.1 Cerebral Aneurysm and AVM Embolization Systems 3.1.1 Market Forecast by Major Geography 3.1.2 Competitive Analysis 3.2 Carotid Stenting Systems and Embolic Protection Devices 3.2.1 Market Forecast by Major Geography 3.2.2 Competitive Analysis 3.3 Left Atrial Appendage Closure Systems 3.3.1 Market Forecast by Major Geography 3.3.2 Competitive Analysis 3.4 Cerebral Thrombectomy Systems 3.4.1 Market Forecast by Major Geography 3.4.2 Competitive Analysis 3.5 Intracranial Stenting Systems 3.5.1 Market Forecast by Major Geography 3.5.2 Competitive Analysis 4. Company Profiles 4.1 Aachen Resonance 4.2 Abbott Vascular (Abbott Laboratories) 4.3 Acandis 4.4 Atricure 4.5 Bard Peripheral Vascular (C.R. Bard) 4.6 Boston Scientific 4.7 Codman/DePuy Synthes (Johnson & Johnson) 4.8 Medtronic/Covidien 4.9 MicroVention (Terumo) 4.10 Neuravi 4.11 Penumbra 4.12 Phenox 4.13 St. Jude Medical 4.14 Stryker 5. Major Country/Regional Profiles 5.1 United States 5.2 Major Europe 5.2.1 France 5.2.2 Germany 5.2.3 Italy 5.2.4 Spain 5.2.5 United Kingdom 5.3 Major Asia-Pacific 5.3.1 China 5.3.2 India 5.3.3 Japan